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【要約】 
Immunonutrition suppresses acute inflammatory 
responses through modulation of resolvin E1 in patients 
undergoing major hepatobiliary resection 
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Structured Abstract 
Objective: To investigate the efficacy of preoperative immunonutrition on surgical 
complications as well as the role of resolvin E1 in inflammatory responses in patients 
undergoing major hepatobiliary resection. 
Summary Background Data: Although several studies have reported the effects of 
immunonutrition on clinical outcomes, detailed mechanisms of immunonutrition after surgery 
are still unclear. It was recently reported that resolvin E1, a novel lipid mediator generated 
from eicosapentaenoic acid (EPA), activates factors that reduce inflammation.  
Methods: This was a prospective, randomized controlled trial. Forty patients who underwent 
major hepatobiliary resection were divided into two groups. Twenty patients received oral 
supplementation enriched with EPA, arginine, and nucleotides before surgery (group IN). 
Twenty patients (control group) received no artificial nutrition before surgery (group C). 
Results: The rate of infectious complications and severity of complications in group IN was 
significantly lower (40%) than in group C (75%) (P < 0.05). Immediately after surgery, 
plasma resolvin E1 levels were significantly higher in group IN than in group C (P < 0.05), 
and plasma IL-6 levels were significantly lower in group IN than in group C (P < 0.05). 
Preoperative serum EPA levels correlated with plasma resolvin E1 levels immediately after 
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surgery. Plasma resolvin E1 levels correlated with plasma IL-6 levels immediately after 
surgery. 
Conclusions: Preoperative immunonutrition reduced inflammatory responses and protected 
against the aggravation of surgical complications in patients undergoing major hepatobiliary 
resection. Resolvin E1 may play a key role in the resolution of acute inflammation when 
immunonutrition is supplemented with EPA. (ClinicalTrials.gov Identifier: NCT01256047） 
 
 
 
 
 
 
 
 
 
 
 
